Head & Neck Cancer Therapeutics Market Size

Head & Neck Cancer Therapeutics Market Size

Head & Neck Cancer Therapeutics Market size was valued at USD 1.8 billion in 2023 and is set to register growth at a CAGR of 8.9% from 2024 and 2032. The growth of this market is primarily driven by the increasing prevalence of head and neck cancer.

To get key market trends

  Download Free Sample

According to statistics published by GLOBOCAN, head and neck cancer is one of the most common cancers globally. Additionally, the growing consumption of tobacco and alcohol, which are major risk factors for head and neck cancers, will further drive industry growth.

Another significant growth driver is the expanding geriatric population base, which is more susceptible to various chronic conditions, thereby elevating market demand. As people age, the likelihood of genetic mutations increases, and the body's ability to repair damaged DNA decreases, leading to a higher risk of cancer. This natural aging process suggests that a larger elderly population will likely result in a higher number of cancer cases. According to the American Cancer Society, about 57% of new cancer cases and 75% of cancer deaths occur in people aged 65 and older. This age group is the fastest-growing segment of the population, particularly in developed countries like the U.S.

Head and neck cancer is defined as a group of cancers that develop in the throat, mouth, nose, larynx, sinuses, or salivary glands. These cancers are typically categorized by the specific area they affect, such as oral, laryngeal, or pharyngeal cancer. The majority of these cancers are referred to as squamous cell carcinomas, as they originate from squamous cells that line the moist surfaces inside the head and neck.